Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | ICELANDAIR GROUP HF | 1 | - | - | |
| OCULIS | 1 | - | -1,03 % | ||
| FESTI | - | 4 | - | |
| HEIMAR | - | 3 | - | |
| JBT MAREL | - | 2 | +0,85 % | ||
| ARION BANK | - | 1 | +1,68 % | ||
| EIMSKIP | - | 1 | - | |
| HAGAR | - | - | - | |
| SKAGI | - | - | - | |
| SJOVA | - | - | - |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Oculis Holding AG: Oculis Publishes Notification of Transactions by Person Discharging Managerial Responsibilities | 3 | GlobeNewswire (USA) | ||
| Fr | Strategische Neuausrichtung im Nordatlantik: Icelandair zieht sich aus Detroit zurück | 2 | Aviation.Direct | ||
| Mi | Icelandair gibt Detroit auf | 3 | aeroTELEGRAPH | ||
| Di | Alvotech vs. Teva Pharma: Which Generic Drugmaker is the Better Play? | 23 | Zacks | ||
| Di | Alvotech upgraded to "buy" by Deutsche Bank as biosimilar launches boost outlook | 10 | Investing.com | ||
| Di | Ära des fliegenden Gletschers endet: Icelandair verabschiedet Boeing 757 mit spezieller Bemalung | 4 | Aviation.Direct | ||
| Di | Alvotech jumps as Deutsche Bank lifts to Buy on 'material thematic opportunity' | 3 | Investing.com | ||
| Di | TF-FIR: Icelandair hat Boeing 757 mit Vatnajökull-Sonderlackierung verabschiedet | 10 | aeroTELEGRAPH | ||
| Mo | Alvotech - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| Mo | EMA committee recommends approval for Alvotech's denosumab biosimilar | 3 | Investing.com | ||
| Mo | EMA-Ausschuss empfiehlt Zulassung für Denosumab-Biosimilar von Alvotech | 3 | Investing.com Deutsch | ||
| Mo | European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech's Proposed Biosimilar to Prolia and Xgeva | 236 | GlobeNewswire (Europe) | REYKJAVIK, Iceland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide... ► Artikel lesen | |
| Mo | Alvotech Reports Positive CHMP Opinion For Gobivaz | 1 | RTTNews | ||
| Mo | Festi hf.: Buyback program week 38 | 2 | GlobeNewswire (USA) | ||
| Mo | European Medicines Agency Recommends Marketing Approval of Gobivaz, Alvotech's Proposed Biosimilar to Simponi (golimumab) with Advanz Pharma as Commercialization Partner | 212 | GlobeNewswire (Europe) | REYKJAVIK, ICELAND and LONDON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients... ► Artikel lesen | |
| Mo | Oculis Holding AG: Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS | 2 | GlobeNewswire (USA) |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .